In the CAT+P (placebo) group, cancer and related therapy was associated with significant changes (POST vs. PRE) in the abundance of seven proteoforms including four intact proteins, one aggregate, and two fragments (Figure 1, Supplementary Table S1). The gene discussed is CAT; the disease is cancer.